Coherus BioSciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. The company's product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, which is used for the treatment of febrile neutropenia; CHS-0214, an etanercept biosimilar candidate, which is in various phases of clinical trials for the treatment of ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, rheumatoid arthritis, and psoriasis; and CHS-5217, a bevacizumab biosimilar candidate, which is in preclinical stage for the treatment of metastatic colorectal cancer, nonsmall cell lung cancer, metastatic kidney cancer, advanced cervical cancer, platinum-resistant ovarian cancer, and recurrent glioblastoma. Its product candidates also comprise CHS-1420, an adalimumab biosimilar candidate, which is in various phases of clinical trials to treat ankylosing spondylitis, Behcet's Disease, Crohn's Disease, juvenile idiopathic arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis; and CHS-3351, a ranibizumab biosimilar candidate, which is in preclinical stage for the treatment of neovascular (wet) age-related macular, degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy. Coherus Biosciences, Inc. has license agreement with Daiichi Sankyo Company, Limited; Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH; Genentech, Inc.; and Selexis SA. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus Biosciences, Inc. in April 2012. Coherus Biosciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
http://www.priceseries.com/trade/CHRS-Coherus-BioSciences-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2018050120180518.html
Related Posts :
IPI Intrepid Potash, Inc gains 35% Nov 2, 2021Intrepid Potash, Inc. produces and sells potash and langbeinite products in the United St… 
CSIQ Canadian Solar Inc. gains 15% Nov 2, 2021Canadian Solar Inc., together with its subsidiaries, designs, develops, manufactures, and… 
EXK Endeavour Silver Corp. gains 18% Nov 2, 2021Endeavour Silver Corp., a mid-tier precious metals mining company, engages in evaluation,… 
NSC Norfolk Souther Corp. gains 15% Nov 2, 2021http://www.priceseries.com/trade/NSC-Norfolk-Souther-Corp-stock-gains-15-percent-a-Trade-… 
HUBS HubSpot, Inc. gains 15% Nov 2, 2021HubSpot, Inc. provides a cloud-based customer relationship management (CRM) platform for …
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments